Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 364

1.

Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.

Tency I, Verstraelen H, Kroes I, Holtappels G, Verhasselt B, Vaneechoutte M, Verhelst R, Temmerman M.

PLoS One. 2012;7(11):e49042. doi: 10.1371/journal.pone.0049042. Epub 2012 Nov 8.

2.

A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection.

Maymon E, Romero R, Pacora P, Gomez R, Mazor M, Edwin S, Chaiworapongsa T, Kim JC, Yoon BH, Menon R, Fortunato S, Berry SM.

J Perinat Med. 2001;29(4):308-16.

PMID:
11565199
3.

Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.

Becher N, Hein M, Danielsen CC, Uldbjerg N.

Reprod Biol Endocrinol. 2010 Sep 24;8:113. doi: 10.1186/1477-7827-8-113.

4.

Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Niebroj-Dobosz I, Janik P, Sokołowska B, Kwiecinski H.

Eur J Neurol. 2010 Feb;17(2):226-31. doi: 10.1111/j.1468-1331.2009.02775.x. Epub 2009 Oct 1.

PMID:
19796283
5.

Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy.

Montagnana M, Lippi G, Albiero A, Scevarolli S, Salvagno GL, Franchi M, Guidi GC.

J Clin Lab Anal. 2009;23(2):88-92. doi: 10.1002/jcla.20295.

PMID:
19288452
6.
7.

Dynamics of activities of matrix metalloproteinases-9 and -2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare.

Oddsdóttir C, Riley SC, Leask R, Shaw DJ, Aurich C, Palm F, Fowden AL, Ricketts SW, Watson ED.

Theriogenology. 2011 Apr 1;75(6):1130-8. doi: 10.1016/j.theriogenology.2010.11.023. Epub 2011 Jan 8.

PMID:
21220153
8.

Matrix metalloproteinases-2, -3 and tissue inhibitors of metalloproteinases-1, -2 in placentas from preterm pregnancies and their association with one-carbon metabolites.

Sundrani D, Chavan-Gautam P, Pisal H, Mehendale S, Joshi S.

Reproduction. 2013 Apr 15;145(4):401-10. doi: 10.1530/REP-12-0520. Print 2013 Apr.

9.

Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.

Mühl D, Nagy B, Woth G, Falusi B, Bogár L, Weber G, Lantos J.

J Crit Care. 2011 Dec;26(6):550-5. doi: 10.1016/j.jcrc.2011.02.011. Epub 2011 May 6.

PMID:
21530151
10.

Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Gomes VA, Vieira CS, Jacob-Ferreira AL, Belo VA, Soares GM, Fernandes JB, Ferriani RA, Tanus-Santos JE.

Mol Cell Biochem. 2011 Jul;353(1-2):251-7. doi: 10.1007/s11010-011-0793-6. Epub 2011 Mar 25.

PMID:
21437624
12.

[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux].

Taranta-Janusz K, Zoch-Zwierz W, Wasilewska A, Tenderenda E, Korzeniecka-Kozerska A.

Pol Merkur Lekarski. 2010 Aug;29(170):88-92. Polish.

PMID:
20842819
13.

Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.

Devlieger R, Riley SC, Verbist L, Leask R, Pijnenborg R, Deprest JA.

J Soc Gynecol Investig. 2002 May-Jun;9(3):137-45.

PMID:
12009387
14.

Matrix metalloproteinases-9 in preterm and term human parturition.

Athayde N, Romero R, Gomez R, Maymon E, Pacora P, Mazor M, Yoon BH, Fortunato S, Menon R, Ghezzi F, Edwin SS.

J Matern Fetal Med. 1999 Sep-Oct;8(5):213-9.

PMID:
10475503
15.

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.

Tayebjee MH, Karalis I, Nadar SK, Beevers DG, MacFadyen RJ, Lip GY.

Am J Hypertens. 2005 Mar;18(3):325-9.

PMID:
15797648
16.

Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity.

Park KH, Chaiworapongsa T, Kim YM, Espinoza J, Yoshimatsu J, Edwin S, Gomez R, Yoon BH, Romero R.

J Perinat Med. 2003;31(1):12-22.

PMID:
12661139
17.

Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.

Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.

J Nephrol. 2007 Jul-Aug;20(4):444-52.

PMID:
17879211
18.

Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.

Stojanovic N, Lewandowski K, Salata I, Bienkiewicz M, Tuck S, Prelevic G, Press M.

Gynecol Endocrinol. 2010 Mar;26(3):201-7. doi: 10.1080/09513590902972026.

PMID:
19526397
19.

Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection.

Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, Yoon BH.

Am J Obstet Gynecol. 2000 Jul;183(1):94-9.

PMID:
10920315
20.

Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.

Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M.

Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.

PMID:
22591289
Items per page

Supplemental Content

Write to the Help Desk